spironolactone ( spl ) corrects hypertension , hypokalemia , and hyporeninemia in patients with primary hyperaldosteronism ( pha ) by blocking mineralocorticoid ( mch ) receptors .
C0037982
spironolactone
C0020621
hypokalemia